Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rahul Banerjee

Showing results (11-20 of 382) with videos related to

Pageof 39
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 25, 2025
Double trouble: Non-relapse mortality with bispecific antibodies in lymphoma and myelomaRahul Banerjee, Samuel Yamshon
JCO Clinical Cancer Informatics|June 22, 2026
Machine Learning for Monoclonal Gammopathy of Undetermined Significance Screening: Who, How, and Why?Aheli Dutta, Rahul Banerjee
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 14, 2015
Occurrence and recall rates of fertility discussions with young breast cancer patientsRahul Banerjee, Ekaterini Tsiapali
JCO Clinical Cancer Informatics|August 12, 2025
Step Count, Step Aside: Newer Physical Activity Metrics to Predict Survival in OncologySanjit Paturi, Rahul Banerjee
Clinical Hematology International|September 29, 2025
Networking for a successful career in clinical hematology: a strategic approachMohamad Mohty, Rahul Banerjee
The Journal of Trauma|May 12, 2009
Removal of a bent intramedullary nail with a posttraumatic sagittal plane deformityRahul Banerjee, Matthew Posner
JAMA Network Open|July 31, 2020
Are Observational, Real-World Studies Suitable to Make Cancer Treatment Recommendations?Rahul Banerjee, Vinay Prasad
Blood Advances|August 15, 2025
Avoid burning bridges before CAR-T therapy in myelomaSwetha Reddi, Rahul Banerjee
Haematologica|February 5, 2026
Post-CAR-T lymphocytosis in multiple myeloma: too much of a good thing?GuiZhen Chen, Rahul Banerjee
JCO Clinical Cancer Informatics|September 30, 2024
Smartwatch Biometrics in the Electronic Medical Record: Time for a New Vital Sign?Srishti Sankaran, Rahul Banerjee
Pageof 39

Showing results (11-20 of 382) with videos related to

Sort By:
Pageof 39
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 25, 2025
Double trouble: Non-relapse mortality with bispecific antibodies in lymphoma and myelomaRahul Banerjee, Samuel Yamshon
JCO Clinical Cancer Informatics|June 22, 2026
Machine Learning for Monoclonal Gammopathy of Undetermined Significance Screening: Who, How, and Why?Aheli Dutta, Rahul Banerjee
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 14, 2015
Occurrence and recall rates of fertility discussions with young breast cancer patientsRahul Banerjee, Ekaterini Tsiapali
JCO Clinical Cancer Informatics|August 12, 2025
Step Count, Step Aside: Newer Physical Activity Metrics to Predict Survival in OncologySanjit Paturi, Rahul Banerjee
Clinical Hematology International|September 29, 2025
Networking for a successful career in clinical hematology: a strategic approachMohamad Mohty, Rahul Banerjee
The Journal of Trauma|May 12, 2009
Removal of a bent intramedullary nail with a posttraumatic sagittal plane deformityRahul Banerjee, Matthew Posner
JAMA Network Open|July 31, 2020
Are Observational, Real-World Studies Suitable to Make Cancer Treatment Recommendations?Rahul Banerjee, Vinay Prasad
Blood Advances|August 15, 2025
Avoid burning bridges before CAR-T therapy in myelomaSwetha Reddi, Rahul Banerjee
Haematologica|February 5, 2026
Post-CAR-T lymphocytosis in multiple myeloma: too much of a good thing?GuiZhen Chen, Rahul Banerjee
JCO Clinical Cancer Informatics|September 30, 2024
Smartwatch Biometrics in the Electronic Medical Record: Time for a New Vital Sign?Srishti Sankaran, Rahul Banerjee
Pageof 39